Clinical trial
Converging Epidemics: Immunobiology of Diabetes Mellitus and Tuberculosis Infection
NCT00568854 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Converging Epidemics: Immunobiology of Diabetes Mellitus and Tuberculosis Infection
- Lead sponsor
- Stanford University
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- April 30, 2007
- Completion date
- March 31, 2008
- Enrollment
- 10 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.